相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies
Krystin Krauel et al.
BLOOD (2012)
Current and Emerging Therapeutics for Heparin-Induced Thrombocytopenia
Adam Cuker
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
A Randomized, Open-Label Pilot Study Comparing Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thrombocytopenia With or Without Thrombosis: PREVENT-HIT Study
Steven W. Boyce et al.
AMERICAN JOURNAL OF THERAPEUTICS (2011)
A Diagnosis of Heparin-Induced Thrombocytopenia with Combined Clinical and Laboratory Methods in Cardiothoracic Surgical Intensive Care Unit Patients
Linda J. Demma et al.
ANESTHESIA AND ANALGESIA (2011)
Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management
Long To et al.
ANNALS OF PHARMACOTHERAPY (2011)
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
Michael P. Reilly et al.
BLOOD (2011)
Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease
Andreas Greinacher et al.
BLOOD (2011)
CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia
Moritz Stolla et al.
BLOOD (2011)
Performance of a new, rapid, automated immunoassay for the detection of anti-platelet factor 4/heparin complex antibodies
Simon J. Davidson et al.
BLOOD COAGULATION & FIBRINOLYSIS (2011)
IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics
Satoru Motokawa et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE
Theodore E. Warkentin et al.
CHEST (2011)
The Frequency and Clinical Significance of Thrombocytopenia Complicating Critical Illness A Systematic Review
Phil Hui et al.
CHEST (2011)
Bilateral adrenal hemorrhage: The unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia
Laura H. Rosenberger et al.
CRITICAL CARE MEDICINE (2011)
Overdiagnosis of Heparin-Induced Thrombocytopenia in Surgical ICU Patients
Cherisse Berry et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2011)
Fondaparinux in acute heparin-induced thrombocytopenia: a case series
M. J. Goldfarb et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies
T. Lhermusier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
HIT paradigms and paradoxes
T. E. Warkentin
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Heparin-induced thrombocytopenia (HIT) in 2011: An epidemic of overdiagnosis
Adam Cuker
THROMBOSIS AND HAEMOSTASIS (2011)
Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT)
Ulrich J. Sachs et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay
Karina Althaus et al.
THROMBOSIS RESEARCH (2011)
The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia
Norbert Lubenow et al.
BLOOD (2010)
β2 Glycoprotein I (β2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome
Marina P. Sikara et al.
BLOOD (2010)
Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia
Nicole L. Whitlatch et al.
BLOOD (2010)
The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients
Mark Andrew Crowther et al.
JOURNAL OF CRITICAL CARE (2010)
Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive
S. Selleng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Outcomes after platelet transfusion in patients with heparin-induced thrombocytopenia
M. A. Refaai et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia
M. Schindewolf et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion
A. Cuker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Fondaparinux: does it cause HIT? can it treat HIT?
Theodore E. Warkentin
EXPERT REVIEW OF HEMATOLOGY (2010)
Incidence of Thrombocytopenia in Hospitalized Patients with Venous Thromboembolism
Paul D. Stein et al.
AMERICAN JOURNAL OF MEDICINE (2009)
The costs of heparin-induced thrombocytopenia: a patient-based cost of illness analysis
T. Wilke et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus
R. Pauzner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia
T. Bakchoul et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
ASH evidence-based guidelines: is the IgG-specific anti-PF4/heparin ELISA superior to the polyspecific ELISA in the laboratory diagnosis of HIT?
A. Cuker et al.
Hematology-American Society of Hematology Education Program (2009)
A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy
Gustavo B. F. Oliveira et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation
Sixten Selleng et al.
BLOOD (2008)
Treatment and prevention of heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
CHEST (2008)
Risk Factors for Major Bleeding in Patients With Heparin-induced Thrombocytopenia Treated With Argatroban: A Retrospective Study
Marcie J. Hursting et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia
Barbara Denys et al.
THROMBOSIS RESEARCH (2008)
Platelet transfusions in heparin-induced thrombocytopenia: a report of four cases and review of the literature
Courtney K. Hopkins et al.
TRANSFUSION (2008)
What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
Gregory K. Lo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital
Maureen A. Smythe et al.
CHEST (2007)
National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK population
Colin A. Hutchison et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Argatroban anticoagulation in critically ill patients
Martin Beiderlinden et al.
ANNALS OF PHARMACOTHERAPY (2007)
The prevalence of antibodies to the platelet factor 4-heparin complex and association with access thrombosis in patients on chronic hemodialysis
Marc Carrier et al.
THROMBOSIS RESEARCH (2007)
Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
BLOOD (2006)
Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin
Bernard Tardy et al.
BLOOD (2006)
Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: Results of the EVOLUTION OFF trial
Andreas Koster et al.
ANESTHESIA AND ANALGESIA (2006)
Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia
BE Lewis et al.
CHEST (2006)
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings
GK Lo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON study
CM Dyke et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2006)
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
TE Warkentin et al.
BLOOD (2005)
Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3
N Lubenow et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Risk for heparin-induced thrombocytopenia. with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
N Martel et al.
BLOOD (2005)
Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome - A nested cohort study
TE Warkentin et al.
CHEST (2005)
Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia
JI Zwicker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass
A Lillo-de Louët et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients
TE Warkentin et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia
A Greinacher et al.
CIRCULATION (2003)
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia
BE Lewis et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin induced thrombocytopenia
AP Hong et al.
BLOOD (2003)
How I treat heparin-induced thrombocytopenia and thrombosis
BM Alving
BLOOD (2003)
Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin
E Lindhoff-Last et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Delayed-onset heparin-induced thrombocytopenia
L Rice et al.
ANNALS OF INTERNAL MEDICINE (2002)
Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study
JA Bittl et al.
AMERICAN HEART JOURNAL (2001)
Temporal aspects of heparin-induced thrombocytopenia
TE Warkentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia
B Pötzsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Users' guides to the medical literature - XXII: How to use articles about clinical decision rules
TG McGinn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
